Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06456294

Evaluation of a Medication Health Center to Promote Opioid Safety

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
14 (estimated)
Sponsor
Kaiser Permanente · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted

Detailed description

Given ongoing concerns about the risk of opioid overdose among people taking chronic opioid therapy for pain, Kaiser Permanente Colorado (KPCO) sought to develop a standardized approach to promote opioid safety. Operational stakeholders adapted an existing Opioid Safety Clinic model, tailored it for KPCO's context, and implemented it in three geographically dispersed KPCO clinics with leadership support. The approach was a multidisciplinary "Medication Health Center" to assess patients, educate them about overdose risk, provide naloxone, and ensure adherence to standard monitoring. Operations and the research team then collaborated to assess the effectiveness of the program to inform decisions to scale the program to other regions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMHC Outreach InterventionAdult PC clinics are randomized to receive the MHC Outreach Intervention early (n=7 clinics) vs. delayed (n=7 clinics). In early intervention clinics, patients prescribed chronic opioid therapy, on a chronic opioid registry, and receiving their medication from the intervention clinic are sent emails and letters inviting them to schedule an MHC appointment. Clinical staff at the early intervention clinic are educated to encourage attendance. During MHC visits, MHC staff assess patients prescribed Chronic Opioid Therapy (COT), educate them about overdose, prescribe naloxone, and order guideline-concordant opioid monitoring.

Timeline

Start date
2022-06-15
Primary completion
2024-12-03
Completion
2025-01-01
First posted
2024-06-13
Last updated
2024-06-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06456294. Inclusion in this directory is not an endorsement.